The predicted share price (Closing Price) for Suven Life Sciences Ltd for tomorrow (2026-04-27) is ₹171.70 which is 30.08% higher than today’s share price of ₹132.00
Suven Life Sciences Ltd – Investor Insights
Valuation StatusiCompares the stock's intrinsic value (calculated from fundamentals like earnings, book value, and growth) with the current market price (CMP). Undervalued = potential buying opportunity. Overvalued = the market may be pricing in too much optimism.
Overvalued
Intrinsic ₹46.18 vs CMP ₹132.00 (-65.0%)
Market RegimeiShows whether the stock is in an uptrend (bullish) or downtrend (bearish) based on its Exponential Moving Average (EMA). When price is above EMA → bullish momentum. Below EMA → bearish pressure. This affects how our model adjusts volatility and predictions.
▼ Bearish
Price/EMA: 0.840 · EMA(252): ₹157.09
VolatilityiMeasures how much the stock price swings. Low (<25%) = stable, predictable price movement. Moderate (25-40%) = normal for most stocks. High (>40%) = large daily swings, higher risk. The "recent trend" shows if volatility is currently increasing or decreasing compared to its historical average.
68.2% annualized
Risk: High · Recent trend: Rising (recent > historical)
Trend MemoryiThe Hurst Exponent measures whether price movements tend to continue (trending) or reverse (mean-reverting). Above 0.55 = momentum persists, recent trends likely to continue. Below 0.45 = price tends to snap back after big moves. Around 0.5 = random walk, past moves don't predict future direction.
Random walk
Hurst exponent: 0.536
Projected CAGRiCompound Annual Growth Rate — the average yearly return if the stock reaches our projected price target. 5Y and 10Y show different time horizons. Higher CAGR = faster expected growth. Negative CAGR = the model projects the stock may decline from current levels.
-3.6%5Y-2%10Y
Historical drift: -5.4% annualized
Risk-Reward RatioiCompares your potential upside (to intrinsic value) against potential downside (to fundamental floor). Above 2x = favorable risk-reward, potential gain is at least double the potential loss. Below 1x = unfavorable, you risk losing more than you could gain. A negative value means the stock is already above intrinsic value.
-0.67x
Upside -65% vs downside 97% · Unfavourable
Margin of SafetyiA concept from value investing (Benjamin Graham). It measures how much cheaper the stock is compared to its intrinsic value. Positive margin = you're buying below fair value (safety cushion). Negative margin = you're paying more than the stock is fundamentally worth. Most value investors look for at least 15-25% margin of safety.
-185.8%
No margin
Model ConfidenceiShows how reliable our predictions are for this stock. Based on the model's average prediction error over the last 90 days. Low error = high confidence. Also shows data coverage — more data points over longer periods produce more reliable projections. The model self-learns by adjusting parameters every 7 days.
Low
Avg error: 10.23% · 507 data points over 613 days
Fundamental FlooriThe lowest price the stock is expected to reach under normal market conditions, based on book value and financial strength (ROE, ROCE, debt ratios). A very low floor relative to CMP means the company has limited tangible asset backing at current prices. In extreme market crashes, prices can temporarily breach this level.
₹3.96
(97% below CMP)
52-Week Range
iShows the stock's lowest and highest closing prices over the past year (~252 trading days). The marker shows where today's price sits within that range. Near the low = potential value opportunity or ongoing weakness. Near the high = momentum or possible overextension.
₹127.00
₹224.00
CMP: ₹132.005% into range41.1% below 52W high
Monthly Return DistributioniBased on historical monthly returns (~21 trading days per month). Shows how many months the stock went up vs down, the best and worst single-month returns, and the win rate. A win rate above 55% with a positive average return indicates consistent performance. High best/worst spread = volatile returns.
Convergence TimelineiShows how long the model expects the stock price to take to converge toward its intrinsic value. The model uses a mathematical convergence rate that pulls the projected price toward intrinsic value gradually. Milestones show the expected price at 25%, 50%, 75%, and 100% convergence. For overvalued stocks, convergence means the price may decline toward intrinsic value.
Target: ₹46.18 in ~5.0 years (2031)
Now ₹13225% ₹11150% ₹8975% ₹68Target ₹46
Gap: 65.0% downward · Model convergence rate: 5.0 years
What this means: Suven Life Sciences Ltd appears overvalued by 65.0% relative to intrinsic value. The stock is currently in a bearish regime (price below EMA). Volatility is high (68.2% annualized), implying wider price swings and higher risk.
Suven Life Sciences Ltd Year-Wise Share Price Target (2027–2036)
Year
Projected Price (₹)
Growth %
CAGR
2027
125.77
-4.7%
-4.7%
Month
Projected Price (₹)
Jan
129.28
Feb
128.29
Mar
126.57
Apr
126.01
May
128.37
Jun
127.88
Jul
125.92
Aug
125.38
Sep
126.95
Oct
126.46
Nov
128.09
Dec
125.77
2028
117.91
-10.7%
-5.5%
Month
Projected Price (₹)
Jan
123.65
Feb
122.15
Mar
121.78
Apr
123.41
May
122.18
Jun
120.69
Jul
119.01
Aug
117.99
Sep
117.15
Oct
116.51
Nov
116.58
Dec
117.91
2029
113.92
-13.7%
-4.8%
Month
Projected Price (₹)
Jan
119.34
Feb
117.66
Mar
118.00
Apr
116.62
May
115.21
Jun
116.22
Jul
114.05
Aug
112.22
Sep
111.47
Oct
110.31
Nov
112.15
Dec
113.92
2030
112.81
-14.5%
-3.9%
Month
Projected Price (₹)
Jan
115.17
Feb
114.76
Mar
115.21
Apr
114.53
May
115.76
Jun
114.27
Jul
114.56
Aug
111.05
Sep
110.44
Oct
108.79
Nov
111.52
Dec
112.81
2031
110.00
-16.7%
-3.6%
Month
Projected Price (₹)
Jan
112.45
Feb
111.86
Mar
111.01
Apr
110.78
May
111.34
Jun
111.60
Jul
110.77
Aug
111.05
Sep
112.34
Oct
112.77
Nov
112.84
Dec
110.00
2032
109.59
-17.0%
-3.1%
Month
Projected Price (₹)
Jan
109.92
Feb
109.63
Mar
110.62
Apr
112.58
May
111.86
Jun
111.86
Jul
110.94
Aug
110.87
Sep
110.85
Oct
110.13
Nov
109.62
Dec
109.59
2033
105.07
-20.4%
-3.2%
Month
Projected Price (₹)
Jan
108.31
Feb
107.08
Mar
105.48
Apr
104.22
May
103.21
Jun
101.80
Jul
101.22
Aug
101.45
Sep
102.92
Oct
102.95
Nov
105.52
Dec
105.07
2034
111.21
-15.8%
-2.1%
Month
Projected Price (₹)
Jan
106.63
Feb
107.21
Mar
104.74
Apr
107.00
May
107.26
Jun
106.72
Jul
108.05
Aug
108.33
Sep
108.76
Oct
111.33
Nov
111.89
Dec
111.21
2035
108.66
-17.7%
-2.1%
Month
Projected Price (₹)
Jan
110.81
Feb
110.32
Mar
110.70
Apr
110.13
May
109.09
Jun
108.58
Jul
107.26
Aug
107.52
Sep
107.39
Oct
108.17
Nov
109.61
Dec
108.66
2036
107.46
-18.6%
-2.0%
Month
Projected Price (₹)
Jan
107.86
Feb
108.30
Mar
105.94
Apr
105.10
May
106.14
Jun
105.71
Jul
106.00
Aug
106.82
Sep
107.03
Oct
109.46
Nov
107.14
Dec
107.46
Suven Life Sciences Ltd Stock Price Analysis
Avg Error (MAPE)iMean Absolute Percentage Error — the average difference between predicted and actual prices, expressed as a percentage. Lower is better. Below 2% = excellent, 2-5% = good, above 5% = the model struggles with this stock.
4.12%
Direction AccuracyiHow often the model correctly predicted whether the price would go up or down the next day. Above 55% = good (better than a coin flip). Above 60% = strong. This matters more than exact price accuracy for trading decisions.
62.2%
Avg Error (₹)iThe average rupee difference between predicted and actual closing prices. For a ₹100 stock, an error of ₹2 means predictions are typically off by about 2%. This gives you a sense of the prediction's precision in absolute terms.
₹6.51
PredictionsiTotal number of daily predictions made for this stock. More predictions = more data for accuracy metrics. The model self-learns and adjusts its parameters every 7 days, so accuracy typically improves over time.
283
Suven Life Sciences Ltd – Historical Performance vs Predictions
Will Suven Life Sciences Ltd share price increase tomorrow?
Suven Life Sciences Ltd share price is expected to increase to ₹171.70 on 2026-04-27, which is 30.08% higher than today's price of ₹132.00. This prediction is based on our AI-powered GFBM model.
What is the intrinsic value of Suven Life Sciences Ltd?
Suven Life Sciences Ltd intrinsic value is ₹46.18, which is 65.02% below the current price of ₹132.00. This suggests the stock is currently overvalued.
What is the share price target of Suven Life Sciences Ltd in 2027?
Suven Life Sciences Ltd share price target for 2027 is projected to reach ₹125.77 by year-end (range: ₹125.38 to ₹129.28), representing a -4.72% decrease from the current price of ₹132.00.
What is the share price target of Suven Life Sciences Ltd in 2028?
Suven Life Sciences Ltd share price target for 2028 is projected to reach ₹117.91 by year-end (range: ₹116.51 to ₹123.65), representing a -10.67% decrease from the current price of ₹132.00.
What is the share price target of Suven Life Sciences Ltd in 2029?
Suven Life Sciences Ltd share price target for 2029 is projected to reach ₹113.92 by year-end (range: ₹110.31 to ₹119.34), representing a -13.70% decrease from the current price of ₹132.00.
Should I buy Suven Life Sciences Ltd stock now?
Based on current analysis, Suven Life Sciences Ltd appears to be a consider reviewing your position candidate. Intrinsic value is ₹46.18 vs CMP ₹132.00. This is not investment advice — consult a SEBI-registered advisor before making investment decisions.
What is the fundamental floor price for Suven Life Sciences Ltd?
The fundamental floor price for Suven Life Sciences Ltd is ₹3.96, calculated from book value and financial strength metrics (ROE, ROCE, debt-to-equity, interest coverage). This is the theoretical minimum price under normal market conditions.
Suven Life Sciences Ltd Share Price Prediction – How We Calculate the Targets
We calculate the share price targets for Suven Life Sciences Ltd using a combined approach of Geometric Fractional Brownian Motion (GFBM) and the Exponential Moving Average (EMA) for trend analysis. This hybrid model incorporates historical price data, memory effects through the Hurst exponent, and dynamic regime shifts based on the stock's trends. Below are the detailed steps of how these projections are calculated.
Step 1: Calculate the Log Returns
The log returns measure the relative change in stock prices over time. It is calculated as follows:
The Hurst exponent measures the "memory" or persistence of the stock price movement. It is calculated as follows:
\[ H = \frac{\log(R/S)}{\log(n)} \]
Step 6: Project Future Share Prices Using GFBM and EMA
The future price of the stock is projected using a combined model of Geometric Fractional Brownian Motion (GFBM) and Exponential Moving Average (EMA) for trend-based regime switching.
Step 7: Predicting Tomorrow's Stock Price for Suven Life Sciences Ltd
The predicted price for tomorrow is derived using the Geometric Brownian Motion (GBM) formula with drift, volatility, and a random factor to simulate market movements.
Step 8: Projected Share Prices for the Next 10 Years
The projected share prices for the next 10 years are calculated using the combined GFBM and EMA model, taking into account historical growth, volatility, and market trends.
Conclusion
Our hybrid approach provides a realistic projection of share prices for Suven Life Sciences Ltd over the next 10 years by considering historical performance, volatility, market memory, and current trends.
The projected stock prices are provided for informational purposes only and do not constitute investment advice or recommendations. Past performance of securities is not indicative of future results. Getaka Financial Technology is not responsible for any investment decisions made on the basis of this information. Investors are advised to seek independent financial advice from a SEBI-registered investment advisor before making any investment decisions. Investments in the securities market are subject to market risks. Please read all associated offer documents and terms carefully before investing.
